SCHEMBL29975793

SCHEMBL29975793

O=C1C(c2c(O)[nH]c3ccccc23)=Nc2cc(Br)ccc21

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GSK3A P49840 15/20 1.00
▸ GSK3B P49841 15/20 1.00
▸ CDK5 Q00535 10/20 0.74
▸ CDK5R1 Q15078 9/20 0.74
▸ CCNE1 P24864 2/20 0.74
▸ CDK2 P24941 2/20 0.74
▸ CCNB2 O95067 3/20 0.73
▸ CDK1 P06493 3/20 0.73
▸ CCNB1 P14635 3/20 0.73
▸ CCNB3 Q8WWL7 3/20 0.73
▸ MEN1 O00255 1/20 0.73
▸ CDK14 O94921 1/20 0.73
▸ MAPT P10636 1/20 0.73
▸ CDK4 P11802 1/20 0.73
▸ SRC P12931 1/20 0.73
▸ CTRB1 P17538 1/20 0.73
▸ CCNA2 P20248 1/20 0.73
▸ CDK11B P21127 1/20 0.73
▸ CCND1 P24385 1/20 0.73
▸ MAPK1 P28482 1/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30319809 0.90 GSK3A (1.00) GSK3AGSK3BCDK5CDK5R1CCNE1
SCHEMBL30319807 0.85 GSK3A (1.00) GSK3AGSK3BCDK5CDK5R1CCNE1
SCHEMBL30273058 0.85 GSK3A (1.00) GSK3AGSK3BCDK5CDK5R1CCNE1
SCHEMBL29421607 0.84 GSK3A (1.00) GSK3AGSK3BCDK5CDK5R1CCNE1
SCHEMBL29364210 0.76 GSK3A (0.71) GSK3AGSK3BCDK5CDK5R1CCNE1
SCHEMBL30597679 0.73 GSK3A (1.00) GSK3AGSK3BCDK5CDK5R1CCNE1
SCHEMBL29648491 0.73 GSK3A (1.00) GSK3AGSK3BCDK5CDK5R1CCNE1
SCHEMBL30597674 0.73 GSK3A (1.00) GSK3AGSK3BCDK5CDK5R1CCNE1
SCHEMBL30094663 0.73 GSK3A (1.00) GSK3AGSK3BCDK5CDK5R1CCNE1
SCHEMBL30319805 0.72 GSK3A (0.76) GSK3AGSK3BCDK5CDK5R1CCNE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4466342-A1 METHOD FOR REPROGRAMMING CD8+ T CELLS TO ENHANCE THEIR THERAPEUTIC POTENTIAL AND APPLICATIONS THEREOF Institut Pasteur (FR) 2024-11-27 — — EP claimed
WO-2023139242-A1 METHOD FOR REPROGRAMMING CD8+ T CELLS TO ENHANCE THEIR THERAPEUTIC POTENTIAL AND APPLICATIONS THEREOF INSTITUT PASTEUR (FR) 2023-07-27 — — WO claimed
EP-4466342-A1 METHOD FOR REPROGRAMMING CD8+ T CELLS TO ENHANCE THEIR THERAPEUTIC POTENTIAL AND APPLICATIONS THEREOF Institut Pasteur (FR) 2024-11-27 — — EP disclosed
CN-114521142-B Compositions and methods for inhibiting and/or treating neurodegenerative diseases and/or clinical conditions thereof CK雷容股份有限公司 2024-07-02 — — CN disclosed
EP-4347674-A1 THERMOREVERSIBLE POLYMERS AND METHODS OF USE THEREOF The Regents of the University of California (US) 2024-04-10 — — EP disclosed
EP-4329748-A1 INDIRUBIN COMPOUNDS AND METHODS THEREOF Jawaharlal Nehru Centre For Advanced Scientific Research (IN) 2024-03-06 — — EP disclosed
WO-2023139242-A1 METHOD FOR REPROGRAMMING CD8+ T CELLS TO ENHANCE THEIR THERAPEUTIC POTENTIAL AND APPLICATIONS THEREOF INSTITUT PASTEUR (FR) 2023-07-27 — — WO disclosed
WO-2022251137-A1 THERMOREVERSIBLE POLYMERS AND METHODS OF USE THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2022-12-01 — — WO disclosed
WO-2022229986-A1 INDIRUBIN COMPOUNDS AND METHODS THEREOF JAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH (IN) 2022-11-03 — — WO disclosed
Send feedback